Dark under-eye circles are difficult to address and require a delicate touch given the sensitivity of the orbital rim. An under-eye product should be gentle, work on the look of dark circles, and provide essential hydration.

QFC fights inflammation while promoting moisturization via Aquaporin-3. In cells and 3D human skin models, QFC has been shown to boost heme oxygenase-1 (HO-1), which helps clear free heme and in turn reduces the appearance of under-eye dark circles.

These bio-cellulose patches are the first to deliver two of Epicutis's active ingredients in one product, with both TSC and QFC working against inflammation.

Size
0.21 oz per mask | Set of 5

• TSC to instantly lock in hydration and calm inflammation
• QFC to reduce the appearance of under-eye dark circles
• Caffeine to reduce puffiness and promote circulation
• Multiple-weight hyaluronic acid for hydration across several layers of skin

Tear open the pouch and remove the mask from the tray. Remove the protective white mesh layer and apply under the eyes. Adjust the mask to contour, then remove the protective blue layer. Smooth the mask evenly on the skin. Leave on for 10-15 minutes. Remove the mask and discard. Gently massage any remaining liquid into the skin. Do not rinse.

KEY INGREDIENTS
TSC (Disodium Tetramethylhexadecenyl Succinoyl Cysteine). Patented super-lipid; locks in hydration and calms inflammation
QFC (Acetylglutaminoyl Farnesylcysteine). Targets the appearance of under-eye dark circles; boosts heme oxygenase-1 in cells and 3D human skin models
Caffeine. Reduces the look of puffiness and promotes circulation
Sodium Hyaluronate + Hydrolyzed Sodium Hyaluronate. Multiple molecular weights for hydration at different depths

FULL INGREDIENTS
Water, Glycerin, Propanediol, Pentylene Glycol, Caffeine, Disodium Tetramethylhexadecenyl Succinoyl Cysteine, Acetylglutaminoyl Farnesylcysteine, Sodium Hyaluronate, Hydrolyzed Sodium Hyaluronate, PPG-13-Decyltetradeceth-24, Sodium Phytate, Citric Acid

Epicutis launched in 2020 on two decades of research from Signum Biosciences, the Princeton University spin-out co-founded in 2003 by biophysicist Dr. Jeffry Stock and Maxwell Stock. Its formulas are built on patented signal-transduction molecules developed in-house, namely TSC, Hyvia®, DSD, ABSO and QFC, and are formulated by Masanori Tamura, previously of Rohto Pharmaceutical and the formulator behind Japan's Hada Labo. Every product is EWG Verified®, vegan and cruelty-free, and free from synthetic fragrance, parabens, sulfates, dyes and gluten. The line is built for the professional channel, designed around the before, during and after of clinical treatment.